Exercise no. 317 Anticoagulants and heavy menstrual bleeding: impact on patients' lives

Prescrire Rédaction,

Women who are treated with an anticoagulant for thrombosis or pulmonary embolism are at risk of heavy menstrual bleeding, i.e. periods that are abnormally heavy or prolonged (menorrhagia). What impact does this menorrhagia have on the everyday lives of these women and their health?

Exercise no. 317 Anticoagulants and heavy menstrual bleeding: impact on patients' lives

Women who are treated with an anticoagulant for thrombosis or pulmonary embolism are at risk of heavy menstrual bleeding, i.e. periods that are abnormally heavy or prolonged (menorrhagia). What impact does this menorrhagia have on the everyday lives of these women and their health?

La suite est réservée à nos abonnés. Déjà abonné ? Se connecter

Faites le choix de l'indépendanceet accédez à tous nos contenusà partir de 19€ par mois

https://www.prescrire.org/pour-cogiter/artmid/1753/articleid/929853/497-exercise-no-316-dostarlimab-jemperli-in-advanced-or-recurrent-endometrial-cancer-with-dna-repair-defects

https://www.prescrire.org/pour-cogiter/498-a-chacun-son-cytochrome

Exercise no. 317 Anticoagulants and heavy menstrual bleeding: impact on patients' lives

Comments are only visible to subscribers.